ArticleScientific reports2025
Eco-friendly synthesis of silver nanoparticles using Anemone coronaria bulb extract and their potent anticancer and antibacterial activities.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antibiotic-chemotherapy interaction in brain tumors: cefazolin reduces chemotherapeutic efficacy of irinotecan in glioblastoma and neuroblastoma cells.Medical oncology (Northwood, London, England) · 2026Article
- Green synthesis of silver nanoparticles under ambient conditions using onion, turmeric, and galangal extracts with antibacterial activity againstBiotechnology reports (Amsterdam, Netherlands) · 2026Article
- Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Silver nanoparticles (AgNPs) have emerged as promising multifunctional agents in biomedical applications due to their notable antimicrobial and anticancer properties. In this study, we present a green, sustainable, and cost-effective method for synthesizing AgNPs using the bulb extract of Anemone coronaria, an underutilized plant part that allows year-round resource-efficient production. The synthesized AgNPs were characterized by UV-Visible spectroscopy, scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR). The nanoparticles exhibited a characteristic UV-Vis absorption peak at 425 nm, spherical morphology with an average size of 29 nm, and a face-centered cubic crystalline structure. FTIR analysis confirmed the presence of phytochemicals involved in the reduction and stabilization of AgNPs. The biosynthesized AgNPs showed potent antibacterial activity against both Gram-positive and Gram-negative bacteria, and demonstrated significant cytotoxic effects on cancer cells while sparing normal cells. Apoptosis induction, cell cycle arrest, and gene expression analyses further validated their anticancer efficacy. These findings highlight the therapeutic potential and biocompatibility of Anemone coronaria-derived AgNPs, offering a green nanotechnological approach for future biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.